Mindful Self-Compassion delivered in person versus by video for anxiety and depression
Official title: Mindful Self-Compassion for Anxiety and Depression: A Randomized Comparison of In-Person Versus Videoconference Delivery
Run by Georgetown University · NCT07028216 · Data updated 2026-11-12
This project will see if an 8-week Mindful Self-Compassion class delivered in person or by video helps people with anxiety or depression have fewer symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Georgetown University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 17, 2026 |
| Study ends | August 31, 2027 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07028216 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a primary diagnosis of social anxiety disorder, generalized anxiety disorder, panic disorder (including agoraphobia), or current major depressive disorder who score low on a self-compassion measure and can attend weekly sessions and study visits.
✕Probably not a fit
Patients with comorbid psychotic disorder, bipolar disorder, current post-traumatic stress disorder, recent substance use disorder, serious medical or cognitive impairment, or those who do not have low self-compassion are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
At Georgetown University adults with a primary anxiety disorder or current major depressive disorder who score low on self-compassion are randomized to an 8-week Mindful Self-Compassion class delivered either in person or by live video-conference. The intervention teaches mindfulness and self-compassion skills in weekly sessions and outcomes include changes in anxiety and depression symptom severity and self-compassion scores measured before and after the program. The trial compares the two delivery methods to determine whether remote delivery is as effective and acceptable as in-person classes. Study visits and standardized symptom/self-compassion measures are used to track changes over time.
Why it matters
Potential benefit: If successful, this program could provide a more accessible way for people with anxiety or depression to reduce symptoms and increase self-compassion.
How similar studies have gone: Previous mindfulness-based interventions have improved self-compassion and reduced anxiety and depression in multiple studies, and early trials of remote delivery have shown promising but mixed results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must have a primary anxiety disorder (social anxiety disorder, generalized anxiety disorder, panic disorder, or agoraphobia) or major depressive disorder, current * Must score low on self-compassion, as measured by the self-compassion scale * Must understand study procedure and willing to participate in all testing visits, and treatment as assigned * Must be able to give informed consent to the study procedures Exclusion Criteria: * Comorbid psychiatric disorder other than anxiety or depression, such as psychotic disorder, obsessive compulsive disorder, eating disorders (i.e., anorexia and bulimia), bipolar disorder; developmental or organic mental disorders; and current (past 6 months) substance use disorders and current post-traumatic stress disorder as assessed by clinician at screening visit * A serious medical condition that may result in surgery or hospitalization. * A history of head trauma causing prolonged loss of consciousness, or ongoing cognitive impairment * Inability to understand study procedures or informed consent process, or significant personality dysfunction likely to interfere with study participation (assessed during the clinical interview). * Subjects who will be non-compliant with the study procedures. This may include planned travel out of town. * Subjects taking some psychiatric medication such as barbiturates or antipsychotics. Sleep medications and some anti-depressants will be allowed, if the subject has been taken at stable dose 8 weeks prior to baseline and the patient plans to continue at the same dose through the trial. * Concurrent psychotherapy initiated within 1 month of screen interview, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety (such as Cognitive Behavioral Therapy). * Individuals who have completed a course of MSC or an equivalent meditation training in the last year. * Individuals reporting significant active suicidal ideation or suicidal behaviors within the past year. * Individuals with a medical condition (i.e., epilepsy) that may be exacerbated by study treatment, as determined by a study physician or nurse practitioner based on history, physical, and/or labs. * Adults unable to consent * Pregnant women * Prisoners
Where it's running
-
Georgetown University Medical Center
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Hoge, MD — Georgetown University
- Study coordinator: Charisma Study Coordinator
- Email: anxietyresearch@georgetown.edu
- Phone: 202-687-7283
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindful Self-Compassion training for anxiety and depression
This study is testing if an 8-week Mindful Self-Compassion training program can help people with anxiety and depression feel better compared to those who don't take the training.
-
Comparing two therapies for treating anxiety disorders
This study is testing two different therapies for anxiety to see which one helps people feel less anxious and improve their mental health better than just learning about anxiety.
-
Stepped versus stratified care for anxiety in children and adolescents
This project tests whether starting all 8–17-year-olds with anxiety on online CBT and adding in-person CBT only if needed (stepped care) works as well as assigning online or in-person CBT up front based on clinical complexity (stratified care).
-
Team-delivered exposure-based CBT for children and teens with anxiety and OCD
This test tries three ways of delivering team-based exposure-focused CBT—in-person, by telehealth, or a flexible mix—to see which works best for kids and teens (ages 5–18) with anxiety or OCD.
-
Using a smartphone app for exposure therapy in anxiety disorders
This study is testing whether using a smartphone app can make exposure therapy more effective for people with anxiety compared to traditional therapy alone.
-
Internet-based treatment for anxiety and depression in adolescents
This study is testing an online treatment for anxiety and depression in Romanian teenagers aged 13-17 to see if it helps them feel better and to find out which teens are most likely to benefit from it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.